563 related articles for article (PubMed ID: 16212072)
1. Current perspective. Diabetic vascular disease: from endothelial dysfunction to atherosclerosis.
Candido R; Zanetti M
Ital Heart J; 2005 Sep; 6(9):703-20. PubMed ID: 16212072
[TBL] [Abstract][Full Text] [Related]
2. [Vascular complications in diabetes mellitus: role of endothelial dysfunction].
Stehouwer CD
Ned Tijdschr Geneeskd; 1996 Apr; 140(16):870-4. PubMed ID: 8692297
[No Abstract] [Full Text] [Related]
3. Thiazolidinediones-improving endothelial function and potential long-term benefits on cardiovascular disease in subjects with type 2 diabetes.
Dandona P; Ghanim H; Chaudhuri A; Mohanty P
J Diabetes Complications; 2008; 22(1):62-75. PubMed ID: 18191079
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance and the endothelium.
Hsueh WA; Lyon CJ; Quiñones MJ
Am J Med; 2004 Jul; 117(2):109-17. PubMed ID: 15234647
[TBL] [Abstract][Full Text] [Related]
5. The proinflammatory and hypercoagulable state of diabetes mellitus.
Aras R; Sowers JR; Arora R
Rev Cardiovasc Med; 2005; 6(2):84-97. PubMed ID: 15976731
[TBL] [Abstract][Full Text] [Related]
6. [The role of endothelial dysfunction in the pathogenesis and in clinical practice of atherosclerosis. Current evidences].
Patti G; Melfi R; Di Sciascio G
Recenti Prog Med; 2005 Oct; 96(10):499-507. PubMed ID: 16491775
[TBL] [Abstract][Full Text] [Related]
7. Why does diabetes mellitus increase the risk of cardiovascular disease?
Shahab A
Acta Med Indones; 2006; 38(1):33-41. PubMed ID: 16479030
[TBL] [Abstract][Full Text] [Related]
8. Endothelial dysfunction in diabetes mellitus.
Cosentino F; Lüscher TF
J Cardiovasc Pharmacol; 1998; 32 Suppl 3():S54-61. PubMed ID: 9883749
[TBL] [Abstract][Full Text] [Related]
9. Does reversal of oxidative stress and inflammation provide vascular protection?
Koh KK; Oh PC; Quon MJ
Cardiovasc Res; 2009 Mar; 81(4):649-59. PubMed ID: 19098298
[TBL] [Abstract][Full Text] [Related]
10. [Relation of polymorphism of genes controlling endothelial function and blood pressure and the occurrence of vascular complications in type 2 diabetes].
Mosorjáková D; Kyslanová L; Kozárová M; Tkác I
Vnitr Lek; 2002 Aug; 48(8):749-54. PubMed ID: 12425206
[TBL] [Abstract][Full Text] [Related]
11. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
Hausenloy DJ; Yellon DM
Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
[TBL] [Abstract][Full Text] [Related]
12. [Atherothrombosis in patients with type 2 diabetes mellitus: an overview of pathophysiology].
Mafrici A; Proietti R
G Ital Cardiol (Rome); 2010 Jun; 11(6):467-77. PubMed ID: 20922872
[TBL] [Abstract][Full Text] [Related]
13. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
14. Ramipril improves oxidative stress-related vascular endothelial dysfunction in db/db mice.
Liang W; Tan CY; Ang L; Sallam N; Granville DJ; Wright JM; Laher I
J Physiol Sci; 2008 Dec; 58(6):405-11. PubMed ID: 18845058
[TBL] [Abstract][Full Text] [Related]
15. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
Yamagishi S; Ueda S; Okuda S
Med Hypotheses; 2007; 69(4):922-4. PubMed ID: 17368960
[TBL] [Abstract][Full Text] [Related]
16. Endothelial integrity, soluble adhesion molecules and platelet markers in type 1 diabetes mellitus.
Blann AD; Lip GY
Diabet Med; 1998 Aug; 15(8):634-42. PubMed ID: 9702464
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis.
Herman AG; Moncada S
Eur Heart J; 2005 Oct; 26(19):1945-55. PubMed ID: 15911567
[TBL] [Abstract][Full Text] [Related]
18. The endothelial dysfunction in diabetes mellitus.
Pănuş C; Moţa M; Vladu D; Vanghelie L; Răducanu CL
Rom J Intern Med; 2003; 41(1):27-33. PubMed ID: 15529582
[TBL] [Abstract][Full Text] [Related]
19. TNF-alpha induces endothelial dysfunction in diabetic adults, an effect reversible by the PPAR-gamma agonist pioglitazone.
Martens FM; Rabelink TJ; op 't Roodt J; de Koning EJ; Visseren FL
Eur Heart J; 2006 Jul; 27(13):1605-9. PubMed ID: 16762982
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
Cersosimo E; DeFronzo RA
Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
